Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Great participation of professionals from Vall d'Hebron in the 2nd National Congress of COVID-19

14 health professionals and researchers are speakers or moderators of round tables to analyze the impact of COVID-19 from different perspectives.

News

Dra. Patricia Pozo Rosich participates in a series of articles on migraine published in The Lancet

The publications review the socioeconomic impact of migraine and the diagnostic and therapeutic advances in this field.

News

#RosesAmbCor, la campanya doblement solidària que protagonitzarà el Sant Jordi d’enguany

La iniciativa repartirà roses entre tots els pacients ingressats a Vall d'Hebron el dia 23 d'abril perquè tots ells i elles puguin gaudir del Sant Jordi encara que no puguin celebrar-lo al carrer.

News

Vall d’Hebron enrolls the first patient in a Phase IIb clinical trial by Oryzon for Borderline Personality Disorder

The PORTICO study will evaluate the efficacy and safety of vafidemstat in Borderline Personality Disorder patients.

News

Red Transfronteriza de interpretación del cribado neonatal: de la mutación al paciente (EFA 086/15)

Pirepred integrará a los hospitales que encargan o realizan pruebas de diagnóstico genético relacionadas con los programas de cribado neonatal, para definir sus necesidades comunes y hacer recomendaciones para mejorar su gestión

News

Self-injurious behaviors are among the main reasons why children and adolescents consult in mental health emergency room

Researchers have analyzed 566 clinical episodes related to mental health problems that they attended in the Pediatric Emergency Room of Vall d'Hebron from 2015 to 2017.

News

Three professionals from Vall d'Hebron, winners of the Spanish Society of Neurology Awards

The SEN Awards 2019 recognize the contribution of Dr. Jorge Pagola, Dr. Miquel Vila and Dr. Patricia-Pozo Rosich in the field of neurological diseases.

News

Caprabo will allocate the money raised in April from the solidarity penny program to Parkinson's research

Vall d'Hebron starts a campaign in collaboration with Caprabo, with the aim of raising funds for the Vall d'Hebron Parkinson Initiative (VHIP) research project, aimed at early detection of the disease.

News

Josep Baselga, former head of Medical Oncology at Vall d'Hebron and first director of the VHIO, dies at 61

Dr. Baselga, internationally renowned medical oncologist from Barcelona, former head of Medical Oncology at Vall d'Hebron and first director of the Vall d'Hebron Institute of Oncology, has died at the age of 61.

News

Genetic variations in testosterone receptor predispose to severe COVID-19 in men

The researchers found that the presence of a high number of repeats of a specific amino acid in the testosterone receptor is related to a worse clinical course of COVID-19.

News

Vall d'Hebron leads a study to improve the treatment of lysosomal disorders

The VHIR develops extracellular vesicles as vehicles for therapeutic enzymes in lysosomal storage disorders.

News

A study demonstrates the effectiveness of a multicomponent treatment for patients with fibromyalgia

The Rheumatology research group has participated in the FIBROWALK study.

News

The BCN-PID Foundation makes a new donation of €30,000 to Vall d’Hebron for the research on primary immunodeficiencies

This donation allows the hiring of a research coordinator in the Infection in Immunocompromised Pediatric Patients group at the VHIR.

News

Dr. Carlos Molina receives the Spirit of Excellence Award that recognizes his commitment to the stroke patient

The award highlights the efforts of the Vall d'Hebron Stroke Unit to care for patients with stroke in times of pandemic and the ability to innovate of Dr. Molina and his team.

News

The Clinical Research Ethics Committee in Vall d’Hebron, the most active in the State

During 2020, it evaluated 105 clinical trials proposals, the highest number in Spain for the fifth consecutive year.

News

Published the results of the Vall d’Hebron study, which shows that minors are low transmitters of SARS-CoV-2

Only 7.7% of pediatric patients with COVID-19 transmitted the SARS-CoV-2 infection to the rest of their family members.

News

Vall d’Hebron develops synthetic erythrocytes that would help global control of influenza viruses

This new tool would facilitate pathogen surveillance and vaccine production control.

News

Dr. Marta Vila rejoins the Research Group in Headache in Vall d’Hebron thanks to a Marie Skłodowska-Curie grant

The aid is valued at euros172,932.48 for two years and will enable to establish a new line of research to study the migraine brain in animal models.

News

Today, we celebrate the International Day of Women

We review the numbers of women working at the VHIR. The VHIR currently employs 1,362 people, of whom 795, or 58%, are women.

News

Vall d’Hebron promotes research against women’s cancer with the fourth edition of the ‘Solidarity Kerchief’

All the profits raised will be used to finance research in women's cancer by two researchers from the Vall d'Hebron Research Institute (VHIR) and the Vall d'Hebron Institute of Oncology (VHIO).